:format(webp)/cdn.mskdoctors.com/storage/2026/8/Ewh8g5cu43sIQRMxdnzj8fpnnY4s4jTS.jpg)
Questions to ask before a ChondroFiller injectionChondroFiller is a Type I collagen hydrogel injected into the joint where it recruits the patient's own progenitor cells to repair cartilage over months rather than days. Specific suitability criteria apply; questions a patient asks beforehand substantially influence whether expectations align with realistic outcomes.ChondroFiller is a Type I collagen hydrogel injected into the joint where it recruits the patient's own progenitor cells to repair cartilage over months rather than days. Specific suitability criteria apply; questions a patient asks beforehand substantially influence whether expectations align with realistic outcomes.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/m5hussZZ9owL5cSOW8JGtSBbGitjmL5I.jpg)
ChondroFiller repeat injections and long-term repairChondroFiller recruits the patient's progenitor cells into a collagen scaffold that degrades over 12–18 months whilst repair tissue develops; 81% of hip patients achieved good or excellent outcomes at three to five years, but success depends heavily on whether osteoarthritis is early-stage or advanced.ChondroFiller recruits the patient's progenitor cells into a collagen scaffold that degrades over 12–18 months whilst repair tissue develops; 81% of hip patients achieved good or excellent outcomes at three to five years, but success depends heavily on whether osteoarthritis is early-stage or advanced.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/19OumF7aZXEESSOqdW6BTloQlHejXoSC.jpg)
ChondroFiller injection for talar dome cartilage defectsChondroFiller is an ultrasound-guided collagen scaffold injection that recruits the patient's own progenitor cells to repair talar cartilage defects over 12–24 months, positioned for lesions exceeding 15 mm that fail conservative care.ChondroFiller is an ultrasound-guided collagen scaffold injection that recruits the patient's own progenitor cells to repair talar cartilage defects over 12–24 months, positioned for lesions exceeding 15 mm that fail conservative care.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/KrFVoOQZ12jhh6MLUrwKAQtNJok3RQHr.jpg)
Knee Cartilage Repair and PreservationArticular cartilage lacks blood vessels, so when damaged it forms fibrocartilage—a mechanically inferior scar tissue that typically deteriorates within two to three years. This biological constraint shapes every treatment option, from temporary symptom relief to procedures attempting true cartilage regeneration.Articular cartilage lacks blood vessels, so when damaged it forms fibrocartilage—a mechanically inferior scar tissue that typically deteriorates within two to three years. This biological constraint shapes every treatment option, from temporary symptom relief to procedures attempting true cartilage regeneration.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/UbCAkAt1jivu18CvklSjgQluD8bXCC2y.jpg)
ChondroFiller injection side effects and safetySwelling and stiffness peak at 24 hours following ChondroFiller injection and resolve within 72 hours as normal tissue responses; the procedure has recorded zero serious adverse effects across more than 19,000 cases since 2013.Swelling and stiffness peak at 24 hours following ChondroFiller injection and resolve within 72 hours as normal tissue responses; the procedure has recorded zero serious adverse effects across more than 19,000 cases since 2013.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/s2hinEoUfUttaBIM2mGAQfUe91yPuSWs.jpg)
ChondroFiller Injection Cost in the UKA ChondroFiller injection costs £3,000 for one box, £5,500 for two, and £8,000 for three; the volume required depends on cartilage defect anatomy, not the joint being treated.A ChondroFiller injection costs £3,000 for one box, £5,500 for two, and £8,000 for three; the volume required depends on cartilage defect anatomy, not the joint being treated.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/5yqtnO9k0Fj59GMzO0kP7LWXrqltF5su.jpg)
When knee pain needs an orthopaedic assessmentMost knee pain settles with rest and physiotherapy; the threshold for orthopaedic assessment is persistent dysfunction despite weeks of conservative care, or acute structural changes—and assessment maps options rather than commits to surgery.Most knee pain settles with rest and physiotherapy; the threshold for orthopaedic assessment is persistent dysfunction despite weeks of conservative care, or acute structural changes—and assessment maps options rather than commits to surgery.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/D2kqxeavVUcZNASzOXi8rxUp6cWpjo8e.jpg)
High tibial osteotomy as a first step in knee preservationHigh tibial osteotomy repositions the tibia to shift weight-bearing from damaged inner knee cartilage to the healthier outer compartment. For younger, active patients, the procedure preserves the natural joint and potentially extends its working life by a decade or more.High tibial osteotomy repositions the tibia to shift weight-bearing from damaged inner knee cartilage to the healthier outer compartment. For younger, active patients, the procedure preserves the natural joint and potentially extends its working life by a decade or more.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/YhbMqNe7YBZk33LsalLldwHMFTQmXyhT.jpg)
ChondroFiller Injection Evidence Patients Should WeighInjected collagen scaffold improves focal cartilage defects by 30 IKDC points — exceeding the minimum clinically important difference — sustaining benefit 2–5 years, though only in joints without advanced osteoarthritis; evidence is limited to small cohorts without a large randomised controlled trial.Injected collagen scaffold improves focal cartilage defects by 30 IKDC points — exceeding the minimum clinically important difference — sustaining benefit 2–5 years, though only in joints without advanced osteoarthritis; evidence is limited to small cohorts without a large randomised controlled trial.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/FEda3Z8zPavpj6fyME29Nts2lLeujPFQ.jpg)
Knee cartilage repair versus stem cell therapyEstablished cartilage repair using autologous chondrocytes shows 10–17 year durability for focal knee defects; mesenchymal stem cell therapies have not been tested in large-scale trials against them.Established cartilage repair using autologous chondrocytes shows 10–17 year durability for focal knee defects; mesenchymal stem cell therapies have not been tested in large-scale trials against them.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/766rT75vrzgAcHwc9vxAXYr5JrU3PaGe.jpg)
ChondroFiller injection versus knee replacement for focal defectsChondroFiller, a gelling collagen scaffold that recruits the patient's own cells to repair cartilage, suits isolated focal defects; knee replacement addresses widespread multi-compartment osteoarthritis.ChondroFiller, a gelling collagen scaffold that recruits the patient's own cells to repair cartilage, suits isolated focal defects; knee replacement addresses widespread multi-compartment osteoarthritis.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/Xc2EYraU36Mqzzl7yRSHjrrwbnM4pNVP.jpg)
ChondroFiller™ durability compared with ArthrosamidChondroFiller™ recruits the patient's own progenitor cells to build new cartilage tissue within a collagen scaffold. Three-year published follow-up shows mean IKDC scores of 80 — a 32.4-point improvement from baseline — with durability reported to extend beyond five years.ChondroFiller™ recruits the patient's own progenitor cells to build new cartilage tissue within a collagen scaffold. Three-year published follow-up shows mean IKDC scores of 80 — a 32.4-point improvement from baseline — with durability reported to extend beyond five years.
